TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 151547

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 microgram four times a day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Salbutamol (200 microgram four times daily)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide and Salbutamol together
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Prednisolone (10 mg three times daily) in addition to both drugs
Number of subjects: 21
Study: 30450642

Group type: EXPERIMENTAL
Intervention: 15 mg/kg 4MP (fomepizole)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 6
Study: 28303422

Group type: COMPARATOR
Intervention: Fun For Wellness (FFW) intervention
Number of subjects: 479
Study: 26501387

Group type: EXPERIMENTAL
Intervention: 70% N2O
Number of subjects: 7112
Study: 24314223

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with vinorelbine plus cisplatin (NP)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Induction chemotherapy with docetaxel plus cisplatin (TP)
Number of subjects: 146
Study: 21821818

Group type: EXPERIMENTAL
Intervention: Camelina meal
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control (50% ground corn and 50% soybean meal)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Crude glycerin (50% soybean meal, 33% ground corn, 15% crude glycerin, 2% corn gluten meal)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Crude glycerin
Number of subjects: 204
Study: 19768640

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (100/6 microg) once daily plus additional doses as needed (SMART)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group treated according to guidelines (medium daily doses of ICS plus SABA if needed)
Number of subjects: 102
Study: 16732085

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20
Study: 15107933

Group type: EXPERIMENTAL
Intervention: Fuzzy model
Number of subjects: 153

Group type: COMPARATOR
Intervention: Multi-discriminant analysis (MDA)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Both methods (MDA and fuzzy)
Number of subjects: 153
Study: 11718986

Group type: EXPERIMENTAL
Intervention: Tumescent technique with subdermal injections of epinephrine, thrombin spray, and warm saline soaked laparotomy pads.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thrombin spray and warm saline soaked laparotomy pads (control group).
Number of subjects: 20
Study: 9812659

Group type: EXPERIMENTAL
Intervention: Caihu Qingxin Yin (CHQXY)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine method using energy mixture
Number of subjects: 52
Study: 8124407

Group type: EXPERIMENTAL
Intervention: Ephedrine/Caffeine combination (20 mg/200 mg) three times a day
Number of subjects: 127

Group type: COMPARATOR
Intervention: Ephedrine alone (20 mg) three times a day
Number of subjects: 127

Group type: COMPARATOR
Intervention: Caffeine alone (200 mg) three times a day
Number of subjects: 127
Study: 3306439

Group type: EXPERIMENTAL
Intervention: Oxaprotiline (150 mg daily for 28 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Clomipramine (150 mg daily for 28 days)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oxaprotiline
Number of subjects: 38

Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 38
Study: 30926992

Group type: EXPERIMENTAL
Intervention: Iron-biofortified beans (86.1 ppm iron)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Comparison beans (50.1 ppm iron)
Number of subjects: 55
Study: 28165812

Group type: EXPERIMENTAL
Intervention: Lipid emulsion (LE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bupivacaine (Bup1000)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Bupivacaine and Lipid emulsion (Bup1000LE)
Number of subjects: 0
Study: 26063354

Group type: EXPERIMENTAL
Intervention: Sarpogrelate (100 mg three times daily for 6 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg once daily for 6 months)
Number of subjects: 120
Study: 23242806

Group type: EXPERIMENTAL
Intervention: n-of-1 trial with methylphenidate
Number of subjects: 50

Group type: COMPARATOR
Intervention: traditional prescription approach
Number of subjects: 50
Study: 21770896

Group type: EXPERIMENTAL
Intervention: Isocapnic hyperpnoea (IH)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional recovery (C)
Number of subjects: 44
Study: 18272842

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration + RAD
Number of subjects: 58

Group type: COMPARATOR
Intervention: CRRT alone
Number of subjects: 58
Study: 16527492

Group type: EXPERIMENTAL
Intervention: Alcohol-laced gelatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-alcoholic placebo gelatin
Number of subjects: 0
Study: 11772801

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120
Study: 10190919

Group type: EXPERIMENTAL
Intervention: Anti-neutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCA) together
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ANCAs
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ANCA pattern characteristic of UC (perinuclear ANCAs eliminated by DNAse)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-titer ANCAs
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ASCA
Number of subjects: 120
Study: 7497486

Group type: EXPERIMENTAL
Intervention: VasoSeal (collagen vascular hemostasis device)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 101
Study: 2301656

Group type: EXPERIMENTAL
Intervention: Marital therapy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 36
Study: 7000296

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg once daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily + Chlorthalidone 25 mg once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31789564

Group type: EXPERIMENTAL
Intervention: Cue-detection group
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Encoding condition
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 145
Study: 28379536

Group type: EXPERIMENTAL
Intervention: Tolvaptan (early treatment)
Number of subjects: 871

Group type: COMPARATOR
Intervention: Placebo (delayed treatment)
Number of subjects: 871
Study: 27111644

Group type: EXPERIMENTAL
Intervention: 19-G multiport wire-reinforced catheter
Number of subjects: 46

Group type: COMPARATOR
Intervention: 19-G uniport wire-reinforced catheter
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both catheter types
Number of subjects: 46
Study: 24618326

Group type: EXPERIMENTAL
Intervention: TSP‐1 rs1478604 A SNP
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: ACA haplotype (rs1478604, rs2228261, rs2228262)
Number of subjects: 378
Study: 22295895

Group type: EXPERIMENTAL
Intervention: (R,S)‐Ket (0.5 mg kg⁻¹) infusion for 40 min
Number of subjects: 9
Study: 19779370

Group type: EXPERIMENTAL
Intervention: Preincisional and postoperative TENS (Group A)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Postoperative TENS only (Group B)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham control (Group C)
Number of subjects: 38
Study: 17698683

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (500 mg/d)
Number of subjects: 8171

Group type: EXPERIMENTAL
Intervention: Vitamin E (600 IU every other day)
Number of subjects: 8171

Group type: EXPERIMENTAL
Intervention: Beta carotene (50 mg every other day)
Number of subjects: 8171

Group type: EXPERIMENTAL
Intervention: Ascorbic acid and Vitamin E (combined)
Number of subjects: 8171
Study: 16202900

Group type: EXPERIMENTAL
Intervention: EMLA cream applied to the groin 60 minutes before the procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prilocaine infiltrated at the site 5 minutes before the procedure (Control)
Number of subjects: 40
Study: 12362933

Group type: EXPERIMENTAL
Intervention: Calcium carbonate 3000 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Calcium acetate 2668 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sevelamer HCl 2821 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Iron alone
Number of subjects: 23
Study: 12669736

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day for 3 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day for 3 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate 20 mg/day for 2 years followed by 5 mg/day for 1 year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7758493

Group type: EXPERIMENTAL
Intervention: Potassium salt of penicillin V, 50,000 U/kg per day in three divided doses
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Benzathine salt of penicillin V, 50,000 U/kg per day in two divided doses
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Benzathine salt of penicillin V, 100,000 U/kg per day in two divided doses
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 3
Study: 2265640

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (within 3 hours)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Intravenous streptokinase (3-6 hours after onset)
Number of subjects: 192
Study: 7410746

Group type: EXPERIMENTAL
Intervention: 1 mg lodoxamide ethyl
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3 mg lodoxamide ethyl
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg lodoxamide ethyl
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 31693081

Group type: EXPERIMENTAL
Intervention: NIRAF-assisted thyroidectomy
Number of subjects: 241

Group type: COMPARATOR
Intervention: Conventional thyroidectomy (control group)
Number of subjects: 241
Study: 30569216

Group type: EXPERIMENTAL
Intervention: CZP 400 mg
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: CZP 200 mg
Number of subjects: 345

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 345
Study: 28333288

Group type: EXPERIMENTAL
Intervention: Vedolizumab induction therapy
Number of subjects: 0
Study: 26914371

Group type: EXPERIMENTAL
Intervention: Project Dulce technology-enhanced with mobile tools (PD-TE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Project Dulce-only (PD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IMSS standard of care/control group (CG)
Number of subjects: 0
Study: 24581318

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular subclavian venous cannulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Landmark method
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 22793965

Group type: EXPERIMENTAL
Intervention: Oral ketoprofen 150 mg preemptively administered every 12 hours for two days before surgery
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo administered every 12 hours for two days before surgery
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral ketoprofen 150 mg administered every 12 hours for three days post-surgery
Number of subjects: 13
Study: 19117872

Group type: EXPERIMENTAL
Intervention: Very early surfactant therapy with nasal continuous positive airway pressure
Number of subjects: 279

Group type: COMPARATOR
Intervention: Nasal continuous airway pressure alone
Number of subjects: 279
Study: 17126951

Group type: COMPARATOR
Intervention: 6 min infusion of vinorelbine
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 1 min bolus of vinorelbine
Number of subjects: 83
Study: 15821618

Group type: EXPERIMENTAL
Intervention: Needlescopic appendectomy (NA)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Conventional laparoscopic appendectomy (CLA)
Number of subjects: 363
Study: 12413984

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) combined with clomiphene citrate (CC)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo combined with clomiphene citrate (CC)
Number of subjects: 230
Study: 9856966

Group type: EXPERIMENTAL
Intervention: Epinephrine (20 ng/kg per minute)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 9
Study: 1507329

Group type: EXPERIMENTAL
Intervention: Siemens Lithostar
Number of subjects: 2206

Group type: EXPERIMENTAL
Intervention: Dornier HM4
Number of subjects: 2206

Group type: EXPERIMENTAL
Intervention: Wolf Piezolith 2300
Number of subjects: 2206

Group type: EXPERIMENTAL
Intervention: Direx Tripter X-1
Number of subjects: 2206

Group type: EXPERIMENTAL
Intervention: Breakstone lithotriptor
Number of subjects: 2206

Group type: COMPARATOR
Intervention: First generation unmodified Dornier HM3 lithotriptor
Number of subjects: 2206
Study: 6089950

Group type: EXPERIMENTAL
Intervention: Ketanserin 40 mg twice daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31397579

Group type: EXPERIMENTAL
Intervention: Hypidone hydrochloride (YL-0919)
Number of subjects: 0
Study: 30028519

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 114

Group type: COMPARATOR
Intervention: Prednisone/prednisolone
Number of subjects: 114
Study: 27119237

Group type: EXPERIMENTAL
Intervention: Ixazomib plus lenalidomide-dexamethasone
Number of subjects: 722

Group type: COMPARATOR
Intervention: Placebo plus lenalidomide-dexamethasone
Number of subjects: 722
Study: 25128004

Group type: EXPERIMENTAL
Intervention: Relating therapy (16 hours, weekly sessions of one hour)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 15
Study: 22897633

Group type: EXPERIMENTAL
Intervention: Individualised goal-directed therapy targeting stroke volume and oxygen delivery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 70
Study: 20632115

Group type: EXPERIMENTAL
Intervention: Integrated yoga
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard antenatal exercises
Number of subjects: 102
Study: 18312661

Group type: EXPERIMENTAL
Intervention: Acupuncture and TENS (A&T)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Acupuncture (ACP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: TENS (TENS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (CT)
Number of subjects: 32
Study: 16635606

Group type: EXPERIMENTAL
Intervention: Statins (atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, or simvastatin)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No-statin group
Number of subjects: 70
Study: 12569384

Group type: EXPERIMENTAL
Intervention: Anthracycline-based neoadjuvant chemotherapy
Number of subjects: 97
Study: 10960802

Group type: EXPERIMENTAL
Intervention: Vinorelbine as a single agent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 0
Study: 9093230

Group type: EXPERIMENTAL
Intervention: Adjunctive corticosteroid therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prophylaxis
Number of subjects: 0
Study: 8334048

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 18
Study: 2953312

Group type: EXPERIMENTAL
Intervention: 0.75% metronidazole gel applied twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle alone (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.75% metronidazole gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both metronidazole and vehicle
Number of subjects: 40
Study: 31201669

Group type: EXPERIMENTAL
Intervention: Formal volunteering for a minimum of 1 hour per week
Number of subjects: 445

Group type: COMPARATOR
Intervention: Control condition (no specific intervention, continue life as usual)
Number of subjects: 445
Study: 29444376

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg (every 4 weeks)
Number of subjects: 168
Study: 27938875

Group type: EXPERIMENTAL
Intervention: Abortion stigma perception (ASP)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Miscarriage stigma perception (MSP)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Comparative stigma perception (CSP)
Number of subjects: 306
Study: 24463236

Group type: EXPERIMENTAL
Intervention: 12-week resistance training program (RTP) for knee extensors muscles
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CG) - no specific training
Number of subjects: 42
Study: 22708706

Group type: EXPERIMENTAL
Intervention: Standardized counseling (Group A)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Non-standardized counseling (Group B)
Number of subjects: 66
Study: 19958076

Group type: EXPERIMENTAL
Intervention: Estrogen plus progesterone therapy (EPT)
Number of subjects: 20
Study: 17503172

Group type: EXPERIMENTAL
Intervention: Adherence self-efficacy
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Self-reported adherence
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Cognitive-oriented interventions
Number of subjects: 275
Study: 15714241

Group type: EXPERIMENTAL
Intervention: Colonic irrigation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Manual decompression
Number of subjects: 53
Study: 14670288

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy with 8-, 15-, and 20-day induction protocols
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group receiving symptomatic treatments
Number of subjects: 53
Study: 10325256

Group type: EXPERIMENTAL
Intervention: Chemiluminescent immunoassay (CLIA)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Radioimmunoassay
Number of subjects: 505
Study: 8696906

Group type: EXPERIMENTAL
Intervention: 2.5mg/h rt-PA for a maximum of 5 hours
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: 10mg rt-PA/h for 5 hours (pilot study)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Controlled technique with rt-PA
Number of subjects: 288
Study: 2061979

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy administered to 733 patients
Number of subjects: 2231

Group type: COMPARATOR
Intervention: No thrombolytic therapy (1498 patients)
Number of subjects: 2231
Study: 6406447

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31062260

Group type: EXPERIMENTAL
Intervention: Statin users (n=5987)
Number of subjects: 19114

Group type: COMPARATOR
Intervention: Non-statin users (n=13127)
Number of subjects: 19114

Group type: EXPERIMENTAL
Intervention: Statin users (unadjusted model)
Number of subjects: 19114

Group type: EXPERIMENTAL
Intervention: Statin users (adjusted model)
Number of subjects: 19114

Group type: EXPERIMENTAL
Intervention: Simvastatin (secondary analysis)
Number of subjects: 19114

Group type: EXPERIMENTAL
Intervention: Statins in individuals with severe obesity (BMI > 35 kg/m2)
Number of subjects: 19114

Group type: EXPERIMENTAL
Intervention: Statins in participants aged 75-84 years
Number of subjects: 19114
Study: 27273863

Group type: EXPERIMENTAL
Intervention: Cricoid pressure during induction of anesthesia
Number of subjects: 95

Group type: COMPARATOR
Intervention: No cricoid pressure during induction of anesthesia
Number of subjects: 95
Study: 26475164

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 60
Study: 24680228

Group type: EXPERIMENTAL
Intervention: Immediate individual cognitive-behavioral therapy for BDD (CBT-BDD), 22 sessions over 24 weeks
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Immediate individual cognitive-behavioral therapy for BDD (CBT-BDD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 36
Study: 21626296

Group type: EXPERIMENTAL
Intervention: diet/probiotic
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: diet/placebo
Number of subjects: 125

Group type: COMPARATOR
Intervention: control/placebo
Number of subjects: 125
Study: 19324913

Group type: EXPERIMENTAL
Intervention: SCORED guideline for CKD screening in heart attack patients
Number of subjects: 6161

Group type: EXPERIMENTAL
Intervention: SCORED guideline for CKD screening in stroke patients
Number of subjects: 6161
Study: 17313282

Group type: EXPERIMENTAL
Intervention: 15 seconds work / 15 seconds recovery (15/15)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30 seconds work / 15 seconds recovery (30/15)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 60 seconds work / 15 seconds recovery (60/15)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous work (C) at 100% of vVO2max
Number of subjects: 12
Study: 15020310

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 200 mg once daily
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 400 mg once daily
Number of subjects: 1702

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg once daily
Number of subjects: 1702

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1702
Study: 12856758

Group type: EXPERIMENTAL
Intervention: Social contact with a lesbian person
Number of subjects: 54

Group type: COMPARATOR
Intervention: No contact with a lesbian
Number of subjects: 54
Study: 9657784

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 400

Group type: COMPARATOR
Intervention: Open mesh hernioplasty
Number of subjects: 400
Study: 7807693

Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin sodium 1 g/1 g b.i.d.
Number of subjects: 125

Group type: COMPARATOR
Intervention: Imipenem/cilastatin sodium 0.5 g/0.5 g q.i.d.
Number of subjects: 125
Study: 2665350

Group type: EXPERIMENTAL
Intervention: BS-WC vaccine
Number of subjects: 62285

Group type: EXPERIMENTAL
Intervention: WC-only vaccine
Number of subjects: 62285

Group type: COMPARATOR
Intervention: Placebo (K12)
Number of subjects: 62285
Study: 15825396

Group type: EXPERIMENTAL
Intervention: Isoprinosine, 6 g a day for 2 days prior to challenge and for 7 post-challenge days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 30935260

Group type: EXPERIMENTAL
Intervention: Phototherapy plus Narrowband UVB plus oral silymarin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Phototherapy with placebo
Number of subjects: 34